OEM Manufacturing

The NPI Capability Gap: What to Ask a Wellness OEM Factory Before You Sign the Brief

Most OEM factory evaluations ask the wrong questions at the wrong stage. The questions that filter capable factories from capable-looking ones are about NPI process—how a factory moves a product from brief to bulk, what validation gates exist, and what happens when a validation stage fails.

Most OEM factory evaluations ask the wrong questions at the wrong stage.

Most OEM factory evaluations ask the wrong questions at the wrong stage.

Procurement teams spend the majority of their supplier assessment time on unit pricing, MOQ thresholds, and sample turnaround. These are legitimate questions, but they are asked too early and they do not surface the information that determines whether a product launches on schedule, within budget, and without the engineering failures that produce return rates and retail chargebacks.

The questions that actually filter capable OEM factories from capable-looking ones are about New Product Introduction process—how a factory moves a product from brief to bulk production, what validation gates exist between those stages, and what happens when a validation stage fails. A factory that has a structured NPI process answers these questions in specific terms. A factory that does not have one gives you a timeline and a price.

This guide gives procurement teams the specific questions to ask at each NPI stage, the numbers that indicate a credible answer, and the responses that indicate a process gap before the deposit is paid.

Why NPI process is the right evaluation lens

A wellness device OEM project has a predictable failure pattern when the factory's NPI process is immature. The brief is accepted without challenge. The sample arrives looking correct. The bulk order is confirmed. Somewhere between the approved sample and the 5,000-unit delivery, variance accumulates—in silicone color consistency, motor resonance, adhesive application, packaging fit. The product that arrives for retail distribution is not the product that was approved. The cost of that variance is absorbed by the brand, not the factory.

That failure pattern is not caused by bad intentions. It is caused by the absence of structured validation gates between NPI phases—checkpoints where specific measurable criteria must be met before the project advances. A factory with a genuine NPI process builds those gates in by design. A factory without one relies on the brand's QC team to catch problems after they have already been manufactured at scale.

The evaluation questions below are designed to surface whether those gates exist before you commit to a project.

Stage 1: Scoping — does the factory push back on your brief?

The first indicator of NPI capability is what happens when you submit a project brief. A factory with a mature process does not simply accept the brief and quote it. They challenge it.

Specifically, a capable factory at the scoping stage will raise conflicts between your target retail price, your required feature set, your compliance requirements, and your timeline before design work begins. They will identify which regional certifications—CE, RoHS, FCC, REACH—apply to your target markets and flag any BOM components that create compliance risk. They will ask about your target MSRP not to understand your margin, but to confirm that the product you are specifying can be manufactured at a cost that makes that price point viable.

Ask the factory: What conflicts have you identified between the brief as submitted and the target specifications? What compliance requirements apply to this product for my target markets, and which of those have you handled before?

A factory that returns your brief with a quote and no questions has not reviewed it for feasibility. They have reviewed it for revenue. Those are different activities with different outcomes for your project.

Stage 2: DFM review — can the factory explain their design decisions?

Design for Manufacturability is the stage where industrial design intent is translated into a production-viable architecture. For wellness devices, this means optimizing internal component placement—motor position relative to battery, PCB layout relative to charging interface, silicone wall thickness relative to display or button integration—so that the product can be assembled consistently at volume without performance compromise.

The practical test of whether a factory has genuine DFM capability is whether they can explain the design decisions they made and why. Not just what the architecture looks like, but what the alternative was and why it was rejected. A factory with real DFM experience will tell you that the motor was repositioned 3mm toward the centerline to reduce resonance transmission to the ABS chassis, or that the battery was rotated to allow a longer silicone overmold run without a join seam. A factory without DFM capability will show you a CAD render and tell you it looks good.

Ask the factory: Walk me through two specific DFM decisions you made on this design and the alternatives you considered. What would the performance or manufacturability consequence have been if you had made the other choice?

For ODM projects involving custom tooling, also ask for the prototyping method before steel tooling begins. SLA resin or CNC-machined prototypes allow ergonomics and dimensional accuracy to be validated physically before the capital expenditure on molds is committed. A factory that moves directly from CAD to steel tooling without a physical prototype stage is compressing the timeline at the expense of validation.

Stage 3: Tooling and EVT — what does a T1 sample actually confirm?

The Engineering Validation Test produces the first samples from completed production tooling—T1 units. This is the stage that most procurement teams treat as the beginning of the evaluation process, when it is actually the end of the design phase. By the time T1 samples arrive, the tooling capital has been spent and significant design changes become expensive.

Understanding what T1 samples are for—and what they are not for—is essential for managing this stage correctly.

T1 samples confirm that the tooling produces the specified geometry, that the silicone color and finish match the approved standard, that the motor configuration delivers the specified performance profile, and that the waterproof architecture survives initial IPX testing. They do not confirm production consistency. They do not confirm that the assembly process can reproduce the sample result across a volume run. A T1 sample is a tooling proof, not a production proof.

Ask the factory: What specific criteria does a T1 sample need to meet before you consider the EVT stage complete? What changes at this stage still fall within normal tooling adjustment, and what changes would require new tooling investment?

The answer to the second question is particularly important for budget management. Minor tooling adjustments—steel removal to open a dimension, surface texture modification—are expected and should be included in the project scope. Major geometry changes after T1 require new tooling and represent a project restart at significant cost. A factory that cannot define this boundary clearly before T1 is a factory that manages cost escalation conversations reactively.

Stage 4: PVT — the validation stage most brands skip

Production Validation Testing is the stage between approved EVT samples and mass production commitment. It produces a small-volume run—typically 50 to 200 units—using the actual production assembly process, the actual production team, and the actual production materials. The purpose is to confirm that the process, not just the tooling, can reproduce the approved sample result.

PVT is the stage most brands skip because it adds time and cost to the NPI timeline. It is also the stage whose absence is most directly correlated with bulk order variance problems. The units that arrive in a bulk order that skipped PVT were produced by a process that was never validated at the assembly level. The variance in those units—color shift, motor resonance variation, seam inconsistency—was built in from the first production day.

Ask the factory: Do you run a PVT stage as a standard part of your NPI process, or is it optional? What sample size do you use for PVT, and what criteria trigger a PVT failure that delays mass production?

A factory that treats PVT as optional is telling you that their confidence in production consistency comes from experience rather than validation data. That may be sufficient for simple products. For a premium wellness device with a hidden display interface, a dual-motor configuration, and an IPX waterproof claim, it is not sufficient.

Stage 5: Lead time benchmarks — what credible numbers look like

Lead time is the NPI metric most frequently discussed and most frequently misrepresented in early-stage supplier conversations. The numbers below reflect realistic timelines for a factory with mature tooling and assembly capabilities—not optimistic estimates designed to win the brief.

For OEM private label projects on an existing product platform—custom logo, custom color, custom packaging on a proven hardware design—a credible lead time from confirmed brief to first production samples is 25 to 35 days. Projects that quote significantly shorter timelines are compressing the sample confirmation process. Projects that quote significantly longer timelines on a standard platform suggest tooling or assembly bottlenecks that will affect your production schedule.

For full ODM projects requiring custom tooling, the NPI cycle breaks into three distinct phases. DFM review and prototyping runs 7 to 10 days for a factory with in-house engineering capability. Steel tooling and EVT sample production runs 30 to 40 days depending on mold complexity. Mass production following PVT approval runs 30 to 35 days. Total NPI cycle from confirmed brief to bulk production ready is 70 to 85 days under normal conditions.

Ask the factory: Break down your quoted lead time by NPI phase. What is your contingency protocol if EVT samples require tooling adjustment, and how does that affect the overall timeline?

A factory that quotes a total timeline without being able to break it into phases does not have a phased process. They have a delivery date and a plan to meet it by whatever means are available when the time comes.

The question that ties all five stages together

After working through stage-specific questions, one closing question synthesizes what you have learned: ask the factory to describe the last NPI project where a validation stage failed and what happened next.

A factory with genuine NPI process experience has answers to this question. Validation stages fail on real projects—tooling produces a geometry variance, a PVT run shows motor resonance outside specification, a thermal cycling test reveals a seal failure. The question is not whether failures occur. The question is whether the factory has a defined protocol for managing them, and whether that protocol protected the client's timeline and budget or transferred the cost and delay to the client.

A factory that has never experienced a validation failure has either never been asked this question honestly or has never had a validation process rigorous enough to catch problems before bulk production. Neither answer gives you confidence in the process.

Evaluate NPI capability with VOVOHO

VOVOHO's **OEM/ODM process** covers the full NPI sequence from project brief through export-ready bulk production, with sample confirmation before production commitment as a standard step. For brands developing **rechargeable personal massager** or **app-controlled wellness** device products, NPI timeline, tooling scope, and validation criteria are confirmed at the scoping stage—not estimated and adjusted later.

If you are working through the broader question of how to structure an OEM project brief before the factory conversation begins, the companion article **The Death of the Wishlist** covers brief structure in detail.

**Request a Quote Start an OEM/ODM Project**